Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions reflect a strong agreement that additional vaccine doses improve immune responses among transplant recipients, with users citing specific studies such as the NEJM publication and French research showing increased antibody production after a third dose. The tone varies from analytical to cautiously optimistic, emphasizing the importance of data interpretation and real-world implications, which contributes to an overall perception of meaningful, albeit moderate, impact on vaccination strategies for immunocompromised groups.
Most discussions acknowledge that the third dose benefits immunocompromised, especially transplant recipients, with many references to studies showing improved antibody responses.
Posts highlight curiosity about the clinical outcomes and data, with users asking about vaccine efficacy, referencing studies, and discussing possible protective measures.
Many comments analyze research data, mention different studies, and evaluate the implications of the findings, indicating deep engagement with the scientific details and context.
While some posts imply the findings could influence vaccine recommendations, others recognize the results as promising but not definitive, suggesting a moderate perceived impact on public health policies.
Bağışıklık sistemi ciddi şekilde baskılanmış olanlara, Organ nakli, kortikosteroid kullanımı vs.. 28 gün sonra "3. doz"-PRİMER SERİ 3 DOZ Bu makaleye göre, orhan nakil alıcılarında 2 doz sonrası yanıt %40 gelişmekte, 3. doz sonrası ancak %68 olmaktadır. https://t.co/NUYfMMuGXG
アメリカで免疫抑制者へのCOVID-19ワクチン3回目接種承認ということで、免疫抑制者である臓器移植患者の3回目接種について。 ファイザー製 https://t.co/4XeHaUyzUf 101人の臓器移植患者対象。 1ヶ月間隔で2回接種し、2ヶ月後に3回目接種。2回目接種後に40％、3回目に68％が抗体陽性に。
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/Xew96OMeKz
‼️‼️@ISHLT @AST_info joint statement on 3rd #COVID vaccine for #transplant @TheJHLT @amjtransplant @ISHLTPres @tcccop: https://t.co/5vvq2NlhOY Evidence from recent @NEJM RCT: https://t.co/HZMrLfYIsx FDA authorization for 3rd dose: https://t.co/5NODFsWcxd
Evidencia https://t.co/GQmSx0lCNw https://t.co/iZBXHUUE1t
This video discusses the impact of three mRNA COVID-19 vaccine doses on solid-organ transplant recipients, showing improved antibody response and highlighting the significance of additional doses for immunocompromised…
The FDA and CDC recommend a third COVID-19 vaccine dose for immunocompromised individuals to improve immune response. Recent studies show that an additional dose enhances antibody levels, providing better protection…
@MunicipalFly @Conservative_BC Transplant patients are much more vulnerable and vaccines are less effective because we take immunosuppressants 2x/day. Even transplanted in 1996 I'm urged to refrain from public events. Even the general population is seeing antivax fallout (measles). https://t.co/TbOrnU4HN5
@CourtneyDGunn @Roman_Baber https://t.co/Gybr2tZLSG https://t.co/G3aIOzz6do
@lndogfarm @ReneGagne8 @AJSextonIII @StevePhillipsMD How do you think they knew elderly, immunocompromised, & solid-organ transplant recipients needed an additional dose? Now you’re just making things up.
@Mistyclark1971 @811monsterbec @Jstnorv10 @TomFitton @DrJBhattacharya Ask and you shall receive. The question is since you call it propaganda will you believe what you see? Here is the doi to a quick search if you need more please Google. DOI: 10.1056/NEJMc2108861 since you asked for peer review you should know how to look this up.
mailは「CDCが試験なしでbooster承認を望んでいた」と示す Stanford大 Jay Bhattacharya博士 https://t.co/TjHrdCCPsN 2 週間もせぬうちにFDAは免疫不全者を含む特定者にbooster承認 https://t.co/NBS4yE8xhx 有効性唯一data 臓器移植 P社3回
RT @MichaelGIsonMD: @ATCMeeting @AST_IDCOP @HumarAtul Two critical studies on SARS-CoV-2 vaccine: https://t.co/c0IfoTv9OM and https://t.co…
@ATCMeeting @AST_IDCOP @HumarAtul Two critical studies on SARS-CoV-2 vaccine: https://t.co/c0IfoTv9OM and https://t.co/gaekB5rlIq
@letskeepit100yo "As of this writing, Covid-19 had not developed in any of the patients after they received the three vaccine doses. No serious adverse events were reported after the administration of the third dose, and no acute rejection episodes occurred." https://t.co/fPre8m8J1F
@Laurentcomplot @JeromeHannick @idrissaberkane Ca c’est dans vos rêves… dans la vraie vie et dans la vraie médecine ça donne ça: https://t.co/4Pe0PB5GkG
@MarieCl86212413 @Gncvrine @idrissaberkane Le vaccin aide beaucoup quand même
@aloa5 Auch im @UlrikeProtzer-Paper wirken ja 2 Impfungen plus Infekt wie Geboostert: https://t.co/QqtuGDo80K Wenn das alles voll zuschlägt, ist die Impfung eine massive Weichenstellung, und nicht geimpft zu sein, kann noch sehr übel werden.
3/3 Per leggere l'articolo, in inglese ⤵️ https://t.co/Hsf4o63E0D #insiemesipuò #AIRPerLaVita
@NorthernPat17 @RebelNewsOnline Also, https://t.co/zdjlwpH28Q
@Davinci3144 @CO1969 @CTVNews Looks like you forgot how vaccinated people who have received an organ transplant still are at a high risk. The only way to protect organ donor recipients is via isolation. If you're going to pretend to be smart please actually reference some data. https://t.co/CIx2ah3OaT
@JohnStr44600263 @Ceeenneffem @VictoriaAKACat @MailOnline Right? So they did quantify it. The source was UCHealth - the nonprofit healthcare org in the US. (Read the article). RE efficacy of vaccine in immunosuppressed - go online, read publications - stop getting your info from twitter.... https://t.co/3sKa6JNSit https://t.co/1KgeKfj9RC
@zilch1 @MedCrisis @PeterAttiaMD Someone who needs a heart transplant is not a normal 31 year old. There is solid evidence that recieving an implant increases your risk factors of covid infection and that immunisation can improve your survivability. https://t.co/vS72Lm99vn https://t.co/G1VMAr211w
@zilch1 @PeterAttiaMD This study shows good immunogenicity to 3 doses of Pfizer's vaccine in transplant recipients. Question is how does this translate into clinical outcomes. https://t.co/WMLQC8DOV9
@hijodelprofe @AzucenaMS Si, justo venía de leer sobre ello https://t.co/UXn7cT8Nfk. Muchas gracias Jesús. Eres otro sol. Me tenéis constantemente iluminado cuando me adentro por las oscuridades del mundo de los patógenos
@PrLantern @AldoSterone111 @JeremyAnso Un contre-exemple : https://t.co/Vb2Eumj8Wa
RT @manopsi: ข้อมูลวัคซีนเข็ม 3 ออกมาแล้ว แต่เป็น mRNA ในผู้ปลูกถ่ายอวัยวะที่กินยากดภูมิ พบว่าฉีด 3 เข็มดีกว่า https://t.co/hOTbuVxV9Q http…
RT @KiranKhush1: Recent publication from France showing 40% of SOT recipients develop anti-SARS CoV2 Abs after 2 doses of the Pfizer vaccin…
@kcremin76 @fitterhappierAJ For reference, it is this study I remembered. https://t.co/4Lngl2xw7O
@drmikehart https://t.co/ry9zLV3ygT After 3 #covid #vaccines people with suppressed immune systems only received 0.004% immunity to #covid. I got the #pneumonia #vaccine instead.
RT @PeterHotez: @JInterlandi There are some data starting to get published https://t.co/i6drTUaD7A
RT @PeterHotez: @JInterlandi There are some data starting to get published https://t.co/i6drTUaD7A
@JInterlandi There are some data starting to get published https://t.co/i6drTUaD7A
@JInterlandi And also: https://t.co/uK9tPueZnE https://t.co/yBUQzkcryL
https://t.co/ry9zLV3ygT
@jeremyrhammond @RebelNewsOnline Many people with a wide range of conditions are excluded from vaccine trials Observational studies of vaccine response in transplant recipients are happening now eg https://t.co/lptWGA9qnR I recommend Google Scholar & PubMed to find more #COVID19
RT @Figure1: Should immunocompromised patients receive a #COVID19 booster and when is the right time to get it? Find out in our latest #Me…
Should immunocompromised patients receive a #COVID19 booster and when is the right time to get it? Find out in our latest #MedEd video! https://t.co/dwakKrfMVE https://t.co/BqjNdS7Pez
Por ese motivo algunos lugares en Francia hay intentando boosters en grupos de pacientes específicos. https://t.co/B4ecqeF0mv
@simpfordrphil @terrydothatch Ok, heres what I found: https://t.co/97Zs55dr2L https://t.co/ujPYbXima9 https://t.co/DefGAJbUhv
What can be done about that? Additional doses for immunocompromised people can sometimes help. 3/ https://t.co/3oJZxLfRb4 https://t.co/d2hYlUomKP
@Bene149 @CarstenWatzl Ja! Zumindest bei Transplantationspatienten: https://t.co/f95BnxEKYb
@patriottakes ❗️ “Severe cases of … [COVID] … have also been reported in transplant recipients who had received two doses of vaccine.3 These reports prompted the French National Authority for Health to recommend the use of a third dose in immunosuppressed patients.” https://t.co/9DlAeB2tVL
@chasrmartin @politicalmath Then there's this paper which investigates 3 doses of Pfizer/BioNTech. 68% developed antibodies after the third dose although, fortunately, none had contracted COVID at the time the paper went to press. https://t.co/3UCYrn6qME
@BasedCorp @IriathZhul @politicalmath You have to show that the outcome is better due to your policy. Here’s the NEJM saying that two jabs gives a very weak response to severe illness in transplant patients. https://t.co/kMrUUrOy30
@Habrutzie @residentJihadi @CTVNews https://t.co/Ks7Cs4u0cR
@Delrane https://t.co/v82lPD0dVn
@AdrianaSpappa @andcapocci @MinisteroSalute Nessuna idea. Gli studi citati (per i più puntigliosi, si tratta di "Correspondence to the Editor") hanno somministrato la terza dose 2 mesi dopo la seconda (che effettivamente è *almeno 28 giorni dopo*) Kamar 2021 https://t.co/7WakHpZHSZ Hall 2021 https://t.co/nhTiOQcV0X
RT @esenol: Bağışıklık sistemi ciddi şekilde baskılanmış olanlara, Organ nakli, kortikosteroid kullanımı vs.. 28 gün sonra "3. doz"-PRİMER…
RT @esenol: Bağışıklık sistemi ciddi şekilde baskılanmış olanlara, Organ nakli, kortikosteroid kullanımı vs.. 28 gün sonra "3. doz"-PRİMER…
RT @esenol: Bağışıklık sistemi ciddi şekilde baskılanmış olanlara, Organ nakli, kortikosteroid kullanımı vs.. 28 gün sonra "3. doz"-PRİMER…
RT @esenol: Bağışıklık sistemi ciddi şekilde baskılanmış olanlara, Organ nakli, kortikosteroid kullanımı vs.. 28 gün sonra "3. doz"-PRİMER…
Bağışıklık sistemi ciddi şekilde baskılanmış olanlara, Organ nakli, kortikosteroid kullanımı vs.. 28 gün sonra "3. doz"-PRİMER SERİ 3 DOZ Bu makaleye göre, orhan nakil alıcılarında 2 doz sonrası yanıt %40 gelişmekte, 3. doz sonrası ancak %68 olmaktadır. https://t.co/NUYfMMuGXG
Sources: my mom and her transplant doctors, https://t.co/ktkbIE418v, https://t.co/Nt9g48AnAz
We also have a few 3 dose studies - notably this small RCT from @UHNTransplant #NephJC https://t.co/yVk1P3EBEK #NephJC https://t.co/94sLmn8iwP
RT @NephJC: We also have a few 3 dose studies - notably this small RCT from @UHNTransplant #NephJC https://t.co/yVk1P3EBEK #NephJC https://…
We also have a few 3 dose studies - notably this small RCT from @UHNTransplant #NephJC https://t.co/yVk1P3EBEK #NephJC https://t.co/dObs9iJmDz
RT @NephJC: T0k. We also have a few 3 dose studies - notably this small RCT from @UHNTransplant #NephJC https://t.co/yVk1P3Wcwi https://t.c…
T0k. We also have a few 3 dose studies - notably this small RCT from @UHNTransplant #NephJC https://t.co/yVk1P3Wcwi https://t.co/LHUtwprOX5
@AlcIdu Bei knapp jedem/jeder zweiten funktioniert es. Ich drücke die Daumen. https://t.co/6oZ4mdI1CH
@Carolin91275583 @GevaertThomas https://t.co/Rf3UgG7Q5e https://t.co/mjHgnfc0Mu https://t.co/omdUfjMHxO https://t.co/3vtO6LnH7V
@giuliere @Fischblog https://t.co/mABzcC9ggf Drücke alle Daumen
RT @DrRomainBrunel: Evidencia https://t.co/GQmSx0lCNw https://t.co/iZBXHUUE1t
RT @DrRomainBrunel: Evidencia https://t.co/GQmSx0lCNw https://t.co/iZBXHUUE1t
Evidencia https://t.co/GQmSx0lCNw https://t.co/iZBXHUUE1t
RT @nefrorantes: @gianking @easegura @TheLancet No aún, solo 3a dosis
@FatmaShamo https://t.co/2EpRvGmdzy https://t.co/xkAzwZQNEa هذه دراستين يوضحون الفائدة من الجرعة الثالثة لبعض الفئات وشلون يتحسن عندهم مستوى المناعة والاجسام المضادة
@aton_everet @j_cocker https://t.co/JEReonEzbP הנה המחקר
@catarinamaia @rsoaresdosreis Para já temos um único estudo (que eu saiba) em transplantados. A resposta imunológica é muito boa ao fim da 3a: https://t.co/LZschMHCKc
RT @trblnfxn: @santiaguero99 https://t.co/uD8K8J4wZb Çalışma 78 böbrek, 12 karaciğer, 8 akciğer/kalp, ve 3 pankreas transplantssyonlu has…
RT @trblnfxn: @santiaguero99 https://t.co/uD8K8J4wZb Çalışma 78 böbrek, 12 karaciğer, 8 akciğer/kalp, ve 3 pankreas transplantssyonlu has…
@santiaguero99 https://t.co/uD8K8J4wZb Çalışma 78 böbrek, 12 karaciğer, 8 akciğer/kalp, ve 3 pankreas transplantssyonlu hasta ile yapılmış. Aşı bu hastalarda güvenilir, bağışıklık yanıtı zayıf olduğu için 3 doz olarak yapılmış.
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/T300aPrbvj
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/ZyPLsLcBSw
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/AoO0xUs3JH
@_benkaufman Apologies, I missed where you said the test group. Anyway, this might help. Personally, if I required a heart transplant, I would trust my consultants and surgeons with their recommendations. https://t.co/pF2odleLDI
@albertarulez @heartembrace @VSCassie @CMOH_Alberta Also here is my reference, it’s a correspondence citing several peer reviewed articles https://t.co/l5la6wKAQA
RT @SantiagoBossa2: https://t.co/l7cpXAg3Q5 3 dosis de Pfizer en inmunocomprometidos.
https://t.co/l7cpXAg3Q5 3 dosis de Pfizer en inmunocomprometidos.
@isagardini1 @Ross_septiembre N Engl J Med 2021 DOI: 10.1056/NEJMc2108861 https://t.co/RdWd3r3fs3
@JeanmarcBenoit And this: https://t.co/hXybyXPGuI
@0___________o @FBAH2020 @ClaytonCraddock @Breaking911 Take your pick on which paper you think hides the truth that scientists are trying to keep from you Oh and here's an article about whether a 3-dose booster is effective https://t.co/NkYUUlc0tr They aren't doing a good job keeping it a secret, publishing it in journals and all
RT @JeffTeuteberg: ‼️‼️@ISHLT @AST_info joint statement on 3rd #COVID vaccine for #transplant @TheJHLT @amjtransplant @ISHLTPres @tcccop: h…
RT @JeffTeuteberg: ‼️‼️@ISHLT @AST_info joint statement on 3rd #COVID vaccine for #transplant @TheJHLT @amjtransplant @ISHLTPres @tcccop: h…
RT @JeffTeuteberg: ‼️‼️@ISHLT @AST_info joint statement on 3rd #COVID vaccine for #transplant @TheJHLT @amjtransplant @ISHLTPres @tcccop: h…
RT @SukunaBikona7: アメリカで免疫抑制者へのCOVID-19ワクチン3回目接種承認ということで、免疫抑制者である臓器移植患者の3回目接種について。 ファイザー製 https://t.co/4XeHaUyzUf 101人の臓器移植患者対象。 1ヶ月間隔で2回接…
RT @JeffTeuteberg: ‼️‼️@ISHLT @AST_info joint statement on 3rd #COVID vaccine for #transplant @TheJHLT @amjtransplant @ISHLTPres @tcccop: h…
RT @JeffTeuteberg: ‼️‼️@ISHLT @AST_info joint statement on 3rd #COVID vaccine for #transplant @TheJHLT @amjtransplant @ISHLTPres @tcccop: h…
RT @JeffTeuteberg: ‼️‼️@ISHLT @AST_info joint statement on 3rd #COVID vaccine for #transplant @TheJHLT @amjtransplant @ISHLTPres @tcccop: h…
‼️‼️@ISHLT @AST_info joint statement on 3rd #COVID vaccine for #transplant @TheJHLT @amjtransplant @ISHLTPres @tcccop: https://t.co/5vvq2NlhOY Evidence from recent @NEJM RCT: https://t.co/HZMrLfYIsx FDA authorization for 3rd dose: https://t.co/5NODFsWcxd
12 de agosto de 2021 Tres dosis de una vacuna de ARNm Covid-19 en receptores de trasplantes de órganos sólidos https://t.co/SJ6LSUleXo
RT @SukunaBikona7: アメリカで免疫抑制者へのCOVID-19ワクチン3回目接種承認ということで、免疫抑制者である臓器移植患者の3回目接種について。 ファイザー製 https://t.co/4XeHaUyzUf 101人の臓器移植患者対象。 1ヶ月間隔で2回接…
RT @SukunaBikona7: アメリカで免疫抑制者へのCOVID-19ワクチン3回目接種承認ということで、免疫抑制者である臓器移植患者の3回目接種について。 ファイザー製 https://t.co/4XeHaUyzUf 101人の臓器移植患者対象。 1ヶ月間隔で2回接…
RT @SukunaBikona7: アメリカで免疫抑制者へのCOVID-19ワクチン3回目接種承認ということで、免疫抑制者である臓器移植患者の3回目接種について。 ファイザー製 https://t.co/4XeHaUyzUf 101人の臓器移植患者対象。 1ヶ月間隔で2回接…
RT @SukunaBikona7: アメリカで免疫抑制者へのCOVID-19ワクチン3回目接種承認ということで、免疫抑制者である臓器移植患者の3回目接種について。 ファイザー製 https://t.co/4XeHaUyzUf 101人の臓器移植患者対象。 1ヶ月間隔で2回接…
RT @SukunaBikona7: アメリカで免疫抑制者へのCOVID-19ワクチン3回目接種承認ということで、免疫抑制者である臓器移植患者の3回目接種について。 ファイザー製 https://t.co/4XeHaUyzUf 101人の臓器移植患者対象。 1ヶ月間隔で2回接…
RT @SukunaBikona7: アメリカで免疫抑制者へのCOVID-19ワクチン3回目接種承認ということで、免疫抑制者である臓器移植患者の3回目接種について。 ファイザー製 https://t.co/4XeHaUyzUf 101人の臓器移植患者対象。 1ヶ月間隔で2回接…
アメリカで免疫抑制者へのCOVID-19ワクチン3回目接種承認ということで、免疫抑制者である臓器移植患者の3回目接種について。 ファイザー製 https://t.co/4XeHaUyzUf 101人の臓器移植患者対象。 1ヶ月間隔で2回接種し、2ヶ月後に3回目接種。2回目接種後に40％、3回目に68％が抗体陽性に。
@Lidapida Jedná se zřejmě o data z této publikace: https://t.co/Sp9MOLWsd8
RT @barriere_dr:
RT @barriere_dr:
RT @ChristianCombe: @Rudy85836234 @jpb331 @christine_kelly @KamarNassim @CHUdeToulouse L’article (court) est en accès libre: https://t.co/3…
RT @christine_kelly: Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/Xew96OMeKz
RT @christine_kelly: Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/Xew96OMeKz
RT @christine_kelly: Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/Xew96OMeKz
RT @christine_kelly: Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/Xew96OMeKz
RT @christine_kelly: Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/Xew96OMeKz
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients | NEJM https://t.co/Xew96OMeKz
@Rudy85836234 @jpb331 @christine_kelly @KamarNassim @CHUdeToulouse L’article (court) est en accès libre: https://t.co/3epn9fkWQK Bonne lecture
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
RT @barriere_dr:
Among solid organ transplantation pts, seropositive rates after third mRNA vaccine improve from 40%, after 2nd dose, to 70%. Retro study in France. https://t.co/LNlXJscX5x
... 10.1056/NEJMra2014530. Serrano OK, Matas AJ. Living donor kidney allograft ... NEJMc2108861. Bertrand D, Hamzaoui M, Lemée V, et al. Antibody and T Cell ...
... 10.1056/NEJMc2108861. Bertrand D, Hamzaoui M, Lemée V, et al. Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant ...
org/doi/full/10.1056/NEJMc2108861 BML: https://www.bmj.com/content/373/bmj. n1116.
org/doi/full/10.1056/NEJMc2108861?f bclid=IwAR39oXC- C3EHCdbdLMpnVzygzdnpKI9ZWSykLa XQ-TYgxypZptyYZh5WOME. nejm.org. Three Doses of an mRNA Covid-19 Vaccine ...
doi: 10.1056/NEJMc2108861. PubMed. Kamar N , Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients . N Engl J Med 2021 ; 385 : 661 ...
... 10.1056/NEJMc2108861. Bertrand D, Hamzaoui M, Lemée V, et al. Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant ...
doi:10.1056/NEJMoa2022483; Boyarsky BJ, Werbel WA, Avery RK, et ... doi:10.1056/NEJMc2108861. Download Issue PDF. Download RIS. Articles in ...
org/doi/full/10.1056/NEJMc2108861 https://www.nejm. org/doi/full/10.1056/NEJMoa2106599 https://jamanetwork. com/journals/jamacardiology ...
... 10.1056/NEJMc2108861 PMID: 34161700 PMCID: 8262620. 46. Shroff RT, Chalasani P, and Wei R, et al (2021) Immune responses to two and three ...
... 10.1056/NEJMc2108861 PMID: 34161700 PMCID: 8262620. Page 14. R esearch ecancer 2022, 16:1355; www.ecancer.org; DOI: https://doi.org/10.3332 ...
doi: 10.1056/NEJMc2108861. pmid:34161700. 9. Greenberger LM, Saltzman LA, Senefeld JW, Johnson PW, DeGennaro LJ, Nichols GL. Anti-spike ...
https://doi.org/10.1056/ · NEJMoa2114228 PMID: 34706170. 3. Lee ARYB ... 1056/NEJMc2108861 PMID: 34161700. PLOS MEDICINE. PLOS Medicine ...
... .05.21256716v1 https://www.nejm.org/doi/full/10.1056/NEJMc2108861 | 花生健康医药Flowergrow Health & Medicine | Facebook. Join Facebook · Video.
2021;doi:10.1056/NEJMc2108861. Kappelman et al. Gastroenterology. 2021;doi:10.1053/j.gastro.2021.06.016. Khan N, et al. Am J Gastroenterol ...
org/doi/full/10.1056/NEJMc2108861?f bclid=IwAR0ueKTmKwPSkk9Mlh3toQk ZYIyAn1Niy6C_gTTsRIYU6z3wuAI1Qx md488. nejm.org. Three Doses of an mRNA ...
This is an antobody study for kidney transplant patients. https://www.nejm. org/doi/full/10.1056/NEJMc2108861 Look up immunosuppressed patients.
https://www.nejm. org/doi/full/10.1056/NEJMc2108861. nejm.org. Three Doses of an mRNA Covid-19 Vaccine in Solid-. 4 yrs. 4. Maros Lukac.
org/doi/full/10.1056/NEJMc2108861?fbclid =IwAR0ueKTmKwPSkk9Mlh3toQkZYIyAn1 Niy6C_gTTsRIYU6z3wuAI1Qxmd488. nejm.org. Three Doses of an mRNA ...
✌️ https://www.nejm. org/doi/full/10.1056/NEJMc2108861. nejm.org. Three Doses of an mRNA Covid-19 Vaccine in Solid-. 4 yrs. 4. JP Brazuka.
... 10.1056/NEJMc2108861?query=featured_home Анагаахын холбогдолтой орчуулга хийлгэх бол энэ дугаарт холбогдох эсвэл fb-р холбогдоорой ...
New England Journal of Medicine. Published online June 23, 2021. doi: 10.1056/NEJMc2108861. R. Redjoul et al. Antibody response after second ...
doi: 10.1056/NEJMc2108861. About the LLS National Patient Registry. The LLS National Patient Registry, a project of the Michael J. Garil ...
org/doi/full/10.1056/NEJMc2108861. nejm.org. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant. 4 yrs. Loading comments... Other ...
Duggar Family News: Life is not all pickles and hairspray. Lauren Wright BS. https://www.nejm. org/doi/full/10.1056/NEJMc2108861. nejm.org.
... ://www.nejm. org/doi/full/10.1056/NEJMc2108861. nejm.org. Three Doses of an mRNA Covid-19 Vaccine in Solid-. 4 yrs. 23. Tippimon Rattanavirote.
... 10.1056/NEJMc2108861. Bertrand D, Hamzaoui M, Lemée V, et al. Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in ...
... of Medicine concerning a third dose of the vaccine for COVID-19 https://www.nejm.org/doi/full/10.1056/NEJMc2108861".
... #BNT162b1 . مترجم : آرشام منبع : https://www.nejm.org/doi/full/10.1056/NEJMc2108861?query=featured_home".
DM
EŞ
S
CK
JT
RB
RH
HG
TP
I
T
IA
MM
JB
OM
I
AE
AW
PS
RB
AO
AD
UG
VS
P
AT
CP
JO
S
IM
PH
CF
P
F
JM
MS
GB
JC
WS
JF
VN
EY
O
İİ
GK
LC
NC
TS
SS
KA
RK
SS
DM
DT
C
نا
M
JM
MK
TI
MO
JG
NM
A
PM
JW
L
?
A
LP
G
JB
S
HP
偐
JM
OM
TI
E
こ
K子
法
一
さT
二
LD
TT
NK
NC
JA
P
RC
S
CC
WF
TM
NG
A
NY
KN
JH
TB
C
MC
RR
VV
M